Then, in three types of cancer, cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), pancreatic adenocarcinoma (PAAD), and stomach adenocarcinoma (STAD), ZNF281 was confirmed as a good prognostic molecular marker considering the high accuracy in the clinical diagnostic feature. This evidence concerns the gene ZNF281 and endocervical adenocarcinoma.